Table 13.
N (%) | |
---|---|
Beta blockers | 185 (26.9) |
Metoprolol | 69 (10.0) |
Propranolol | 41 (6.0) |
Atenolol | 37 (5.4) |
Carvedilol | 13 (1.9) |
Labetalol | 13 (1.9) |
Nebivolol | 6 (0.9) |
Miscellaneousa | 6 (0.9) |
Calcium channel antagonists | 116 (16.9) |
Amlodipine | 61 (8.9) |
Diltiazem | 24 (3.5) |
Verapamil | 19 (2.8) |
Nifedipine | 10 (1.5) |
Miscellaneousb | 2 (0.3) |
ACE inhibitors | 64 (9.3) |
Lisinopril | 53 (7.7) |
Enalapril | 6 (0.9) |
Miscellaneousc | 6 (0.9) |
Angiotensin receptor blockers | 10 (1.5) |
Losartan | 6 (0.9) |
Miscellaneousd | 4 (0.6) |
Cardiac glycosides | 53 (7.7) |
Digoxin | 52 (7.6) |
Digitoxin | 1 (0.1) |
Sympatholytics | 154 (22.4) |
Clonidine | 129 (18.8) |
Guanfacine | 21 (3.1) |
Xylazine | 4 (0.6) |
Diuretics | 32 (4.7) |
Hydrochlorothiazide | 10 (1.5) |
Furosemide | 9 (1.3) |
Miscellaneouse | 13 (1.9) |
Other antihypertensives and vasodilators | 44 (6.4) |
Prazosin | 13 (1.9) |
Cilostazol | 11 (1.6) |
Miscellaneousf | 20 (2.9) |
Antidysrhythmics | 11 (1.6) |
Amiodarone | 5 (0.7) |
Miscellaneousg | 6 (0.9) |
Other cardiovascular agents | 12 (1.7) |
Atorvastatin | 5 (0.7) |
Miscellaneoush | 7 (1.0) |
aIncludes nadolol, bisoprolol, and pindolol
bIncludes aranidipine and felodipine
cIncludes benazepril, perindopril, quinapril
dIncludes valsartan, and candesartan
eIncludes acetazolamide, spironolactone, pamabrom, chlorthalidone, and torsemide
fIncludes alkyl nitrite, isosorbide, antihypertensive unspecified, doxazosin, nitroglycerin, terazosin, amyl nitrite, hydralazine, and tamsulosin
gIncludes propafenone, flecainide, and mexiletine
hIncludes cardiovascular agent unspecified, lovastatin, pravastatin, and ranolazine